ArticleCureus2025
A Multifaceted Presentation of the Retrocorneal Membrane Following Intraocular Surgery: A Case Series.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The retrocorneal membrane is a rare but serious complication of intraocular surgery, presenting in varied forms. This case series highlights three patients who developed retrocorneal membranes following different ocular procedures. The first case involves a 67-year-old man with a history of right open globe rupture. He underwent multiple surgeries and developed corneal decompensation, for which Descemet stripping automated endothelial keratoplasty (DSAEK) was performed. He later developed a recurrent epithelial downgrowth (EDG) membrane. The second case presents a 79-year-old man who presented with a worsening vision to 3/60, one year after a complicated cataract surgery, due to a temporally growing fibrous downgrowth. The third describes a 70-year-old man who experienced blurred vision with visual acuity (VA) of 6/60, caused by a nasally growing fibrous downgrowth 10 months post-endothelial keratoplasty. All patients underwent retrocorneal membrane peeling combined with intracameral 5-fluorouracil (5-FU) treatment. This report discusses their clinical presentations, ocular imaging, treatment approaches, and histopathological findings. Retrocorneal membranes, particularly EDG, are difficult to manage and often result in poor visual outcomes despite treatment. While histopathology (HPE) remains the gold standard for diagnosis, clinical evaluation, anterior segment optical coherence tomography (AS-OCT), and regular follow-up are essential in guiding management. Further research is needed to improve the understanding and treatment of this rare condition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.